Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2050427 | 1.00 | — | — | |
| SCHEMBL23735487 | 0.93 | EPHX2 (0.56) | EPHX1EPHX2MAPTNPC1RAB9A | |
| SCHEMBL28580041 | 0.91 | EPHX1 (0.41) | EPHX1EPHX2NPSR1MMP2MMP8 | |
| SCHEMBL13698908 | 0.91 | EPHX1 (0.55) | EPHX1MMP2MMP8NPC1RAB9A | |
| SCHEMBL17407561 | 0.91 | EPHX2 (0.60) | EPHX1EPHX2NPSR1MMP2MMP8 | |
| SCHEMBL12385850 | 0.91 | EPHX1 (0.55) | EPHX1MMP2MMP8NPC1RAB9A | |
| SCHEMBL18814222 | 0.91 | ATM (0.45) | EPHX1EPHX2NPSR1MMP2MMP8 | |
| SCHEMBL5949945 | 0.91 | EPHX1 (0.55) | EPHX1MMP2MMP8NPC1RAB9A | |
| SCHEMBL22311485 | 0.91 | EPHX2 (0.60) | EPHX1EPHX2NPSR1MMP2MMP8 | |
| SCHEMBL12513461 | 0.91 | ATM (0.45) | EPHX1EPHX2NPSR1MMP2MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8927763-B2 | Method for preparing aliphatic diisocyanate | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2015-01-06 | — | — | US | claimed |
| US-20140303399-A1 | METHOD FOR PREPARING ALIPHATIC DIISOCYANATE | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2014-10-09 | — | — | US | claimed |
| US-8927763-B2 | Method for preparing aliphatic diisocyanate | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2015-01-06 | — | — | US | disclosed |
| US-20140303399-A1 | METHOD FOR PREPARING ALIPHATIC DIISOCYANATE | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2014-10-09 | — | — | US | disclosed |
| US-5914428-A | REACTING DIMETHYL CARBONATE WITH AN ALIPHATIC DIAMINE IN PRESENCE OF AN ALKALI METAL OR COMPOUND AS CARBAMYLATION CATALYST TO FORM CARBAMATE, THERMALLY DECOMPOSING THE PRODUCT IN HIGH BOILING SOLVENT TO PRODUCE ALIPHATIC DIISOCYANATE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-22 | — | — | US | disclosed |
| US-5789614-A | Process for preparation of aliphatic diisocyanate compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-08-04 | — | — | US | disclosed |
| US-5773643-A | Process for preparation of isocyanate compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-06-30 | — | — | US | disclosed |
| EP-0323514-B1 | PROCESS FOR PREPARING ISOCYANATE COMPOUNDS | DAICEL CHEM (JP) | 1994-07-13 | — | — | EP | disclosed |
| EP-0477376-A1 | PROCESS FOR PRODUCING POLYURETHANE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1992-04-01 | — | — | EP | disclosed |
| EP-0323514-A1 | PROCESS FOR PREPARING ISOCYANATE COMPOUNDS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140303399-A1 | METHOD FOR PREPARING ALIPHATIC DIISOCYANATE | ALKBH3, DDC, ALKBH5 | EPHX1 3411/4885EPHX2 1207/4885NPSR1 4035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.